首頁 > 市場調查報告書 > 醫療設備

泌尿科

市場調查報告書

商品編碼

1377385

男性人工尿道括約肌市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按類型（帶氣球儲液器的 AUS、帶彈簧的 AUS）、最終用戶、地區和競爭細分

Male Artificial Urinary Sphincter Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type (AUS with a balloon reservoir, AUS with a spring ), By End-user, By Region, and Competition

出版日期: 2023年10月03日 | 出版商:

TechSci Research | 英文 175 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2022 年，全球男性人工尿道括約肌市場價值為 2.2645 億美元，預計在預測期內將出現令人印象深刻的成長，到 2028 年CAGR為5.39%。尿失禁(UI) 是一個重大的健康問題，具有重大的經濟和社會影響。男性尿失禁病例的增加可歸因於泌尿系統疾病的日益流行，例如前列腺炎引起的尿失禁、手術引起的神經和肌肉損傷以及感染等因素，所有這些都會導致膀胱破裂功能。一個潛在的因素是前列腺肥大，這是一種被稱為良性前列腺增生的疾病，它往往隨著年齡的成長而發生。另一個潛在的觸發因素是前列腺炎，其特徵是前列腺發炎。此外，手術介入引起的神經和肌肉損傷也可能導致失禁。

主要市場促進因素

人口老化加劇

市場概況
預測期	2024-2028
2022 年市場規模	2.2645億美元
2028 年市場規模	3.0926億美元
2023-2028 年CAGR	5.39%
成長最快的細分市場	醫院
最大的市場	北美洲

隨著世界人口老化程度空前增加，全球醫療保健格局正經歷變革。隨著長壽成為常態，與年齡相關的疾病正在增加，其中之一就是尿失禁。世界正在經歷一場人口革命，全球很大一部分人口進入了黃金歲月。據聯合國稱，到 2050 年，60 歲及以上的人口預計將增加近一倍，從 2017 年的 9.62 億增加到約 21 億。這一重大的人口變化正在創造一個不斷擴大的潛在患者群體，需要治療與年齡相關的健康問題，包括尿失禁。尿失禁是一種以尿液不自主滲漏為特徵的疾病，在老年人中更為常見。老化會帶來各種生理變化，例如肌肉衰弱和荷爾蒙失衡，導致尿失禁。此外，良性攝護腺增生（BPH）和攝護腺炎等與年齡相關的疾病也是常見的罪魁禍首。隨著人口老化的成長，這些疾病的盛行率也在增加，因此需要有效的治療方案。老年人對提高生活品質的渴望是男性人工尿道括約肌市場成長的重要驅動力。尿失禁會對個人的日常生活產生深遠的影響，導致社會孤立、尷尬和失去獨立性。認知到維護老年人的尊嚴和福祉的重要性，醫療保健提供者擴大推薦男性人工尿道括約肌作為解決方案。隨著人口老化，醫療技術的進步改善了男性人工尿道括約肌的設計和有效性。現代設備可以更好地控制泌尿功能、減少併發症並提高患者的舒適度。這些創新使這些設備成為尋求恢復獨立和生活品質的老年人更具吸引力和可行的選擇。隨著人口老化的成長，醫療保健支出也隨之增加。政府和私人醫療保健提供者正在分配更多資源來滿足老年人的獨特需求。對醫療基礎設施和服務的投資增加包括採用先進的醫療技術，例如男性人工尿道括約肌，這對於提高護理品質和老年患者的整體福祉至關重要。

市場規模及預測
- 按價值
市佔率及預測
- 按類型（帶球囊儲液器的 AUS（3 組件）、帶彈簧的 AUS（2 組件））
- 按最終使用者（醫院、診所和其他醫療中心、學術和研究中心）
- 按地區
- 按公司分類 (2022)
產品市場地圖
- 按類型
- 按最終用戶
- 按地區

第 6 章：北美男性人工尿道括約肌市場展望

市場規模及預測
- 按價值
市佔率及預測
- 按類型（帶球囊儲液器的 AUS（3 組件）、帶彈簧的 AUS（2 組件））
- 按最終使用者（醫院、診所和其他醫療中心、學術和研究中心）
- 按國家/地區
北美：國家分析
- 美國
- 加拿大
- 墨西哥

第 7 章：歐洲男性人工尿道括約肌市場展望

市場規模及預測
- 按價值
市佔率及預測
- 按類型（帶球囊儲液器的 AUS（3 組件）、帶彈簧的 AUS（2 組件））
- 按最終使用者（醫院、診所和其他醫療中心、學術和研究中心）
- 按國家/地區
歐洲：國家分析
- 德國
- 英國
- 法國
- 義大利
- 西班牙

第 8 章：亞太地區男性人工尿道括約肌市場展望

市場規模及預測
- 按價值
市佔率及預測
- 按類型（帶球囊儲液器的 AUS（3 組件）、帶彈簧的 AUS（2 組件））
- 按最終使用者（醫院、診所和其他醫療中心、學術和研究中心）
- 按國家/地區
亞太地區：國家分析
- 中國
- 日本
- 印度
- 澳洲
- 韓國

第 9 章：南美洲男性人工尿道括約肌市場展望

市場規模及預測
- 按價值
市佔率及預測
- 按類型（帶球囊儲液器的 AUS（3 組件）、帶彈簧的 AUS（2 組件））
- 按最終使用者（醫院、診所和其他醫療中心、學術和研究中心）
- 按國家/地區
南美洲：國家分析
- 巴西
- 阿根廷
- 哥倫比亞

第 10 章：中東和非洲男性人工尿道括約肌市場展望

市場規模及預測
- 按價值
市佔率及預測
- 按類型（帶球囊儲液器的 AUS（3 組件）、帶彈簧的 AUS（2 組件））
- 按最終使用者（醫院、診所和其他醫療中心、學術和研究中心）
- 按國家/地區
MEA：國家分析
- 南非男性人工尿道括約肌
- 沙烏地阿拉伯男性人工尿道括約肌
- 阿拉伯聯合大公國男性人工尿道括約肌
- 科威特男性人工尿道括約肌

第 11 章：市場動態

促進要素
挑戰

第 12 章：市場趨勢與發展

近期發展
併購
產品發布

第 13 章：波特的五力分析

產業競爭
新進入者的潛力
供應商的力量
客戶的力量
替代產品的威脅

第14章：競爭格局

商業概覽
產品供應
最近的發展
財務（據報導）
主要人員
SWOT分析
- Boston Scientific Corporation
- Zephyr Surgical Implants
- Affluent Medical
- UroMems
- Rigicon
- ProMinent GmbH

第 15 章：策略建議

第 16 章：關於我們與免責聲明

簡介目錄

Product Code: 16618

Global Male Artificial Urinary Sphincter Market has valued at USD 226.45 million in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 5.39% through 2028. Urinary Incontinence (UI) represents a significant health concern with substantial economic and societal implications. The increase in cases of male urinary incontinence can be attributed to the growing prevalence of urological ailments, such as prostatitis-induced incontinence, nerve and muscle damage resulting from surgical procedures, and infections, among other factors, all of which contribute to disruptions in bladder function. One potential factor is the enlargement of the prostate gland, a condition known as benign prostate hyperplasia, which tends to occur with age. Another potential trigger is prostatitis, characterized by inflammation of the prostate gland. Furthermore, incontinence can also arise as a consequence of nerve and muscle impairment caused by surgical interventions.

Key Market Drivers

Rising Aging Population

Market Overview
Forecast Period	2024-2028
Market Size 2022	USD 226.45 Million
Market Size 2028	USD 309.26 Million
CAGR 2023-2028	5.39%
Fastest Growing Segment	Hospitals
Largest Market	North America

The global healthcare landscape is undergoing a transformative shift as the world witnesses an unprecedented increase in the aging population. As longevity becomes the norm, age-related medical conditions are on the rise, one of which is urinary incontinence. The world is witnessing a demographic revolution, with a substantial portion of the global population entering their golden years. According to the United Nations, the number of people aged 60 and over is expected to nearly double by 2050, from 962 million in 2017 to an estimated 2.1 billion. This significant demographic shift is creating an ever-expanding pool of potential patients in need of treatment for age-related health issues, including urinary incontinence. Urinary incontinence, a condition characterized by the involuntary leakage of urine, is more prevalent among older adults. Aging brings about various physiological changes, such as muscle weakening and hormonal imbalances, which can contribute to urinary incontinence. Additionally, age-related medical conditions like benign prostate hyperplasia (BPH) and prostatitis are common culprits. As the aging population grows, so does the prevalence of these conditions, necessitating effective treatment options. The desire for an improved quality of life among the elderly is a significant driving force behind the growth of the male artificial urinary sphincter market. Urinary incontinence can have a profound impact on an individual's daily life, leading to social isolation, embarrassment, and a loss of independence. Recognizing the importance of preserving the dignity and well-being of older adults, healthcare providers are increasingly recommending male artificial urinary sphincters as a solution. In tandem with the aging population, advancements in medical technology have improved the design and effectiveness of male artificial urinary sphincters. Modern devices offer better control over urinary function, fewer complications, and enhanced patient comfort. These innovations have made these devices a more attractive and viable option for older individuals seeking to regain their independence and quality of life. As the aging population grows, so does healthcare spending. Governments and private healthcare providers are allocating more resources to address the unique needs of older adults. This increased investment in healthcare infrastructure and services includes the adoption of advanced medical technologies, such as male artificial urinary sphincters, which are crucial for improving the quality of care and the overall well-being of aging patients.

Prevalence of Urological Disorders

The global healthcare landscape is witnessing a surge in the prevalence of urological disorders, and this phenomenon is reshaping the landscape of medical technology. One significant beneficiary of this trend is the male artificial urinary sphincter market. Urological disorders encompass a range of conditions affecting the urinary tract and male reproductive organs. These disorders include benign prostate hyperplasia (BPH), prostatitis, and other ailments that can lead to urinary incontinence. The global prevalence of these disorders has been on the rise, primarily due to factors such as aging demographics and changes in lifestyle. As the global population ages, the incidence of urological disorders, particularly those associated with aging, has increased significantly. BPH, a non-cancerous enlargement of the prostate gland, is a prime example. It is estimated that by the age of 60, over 50% of men will experience symptoms of BPH. These conditions often lead to urinary incontinence, which necessitates effective management and treatment options like male artificial urinary sphincters. Urological disorders, when left untreated, can have a profound impact on an individual's quality of life. Frequent urination, discomfort, and urinary incontinence can lead to social isolation, reduced mobility, and emotional distress. As awareness of these quality-of-life issues grows, patients and healthcare providers alike are seeking more advanced and reliable solutions. Male artificial urinary sphincters have emerged as a lifeline for individuals battling urological disorders that result in urinary incontinence. These devices are designed to provide precise control over urinary function, offering patients greater independence and an enhanced quality of life. The rising prevalence of urological disorders has driven increased demand for these innovative solutions. The growth of the male artificial urinary sphincter market is further propelled by continuous advancements in medical technology. Modern devices are more sophisticated, user-friendly, and associated with fewer complications. This encourages both healthcare providers and patients to consider these solutions as a viable option for managing urological disorders. Growing awareness about urological disorders and the available treatment options is another pivotal factor. Patients are now more informed about their conditions, leading to proactive healthcare-seeking behaviors. Healthcare providers, in turn, are better educated about the benefits of male artificial urinary sphincters and are more inclined to recommend them as part of a comprehensive treatment plan.

Advancements in Medical Technology

In an era characterized by relentless innovation, medical technology has become a driving force behind advancements in healthcare. One area where this is particularly evident is in the growth of the global male artificial urinary sphincter market. Advancements in medical technology have revolutionized the way we diagnose, treat, and manage various health conditions. This holds true for the field of urology and the treatment of male urinary incontinence. Modern medical technology is enabling healthcare professionals to provide more effective, minimally invasive, and patient-centric solutions. One of the key factors driving the growth of the male artificial urinary sphincter market is the increased precision and control offered by advanced technologies. These devices have evolved to provide patients with a high degree of control over urinary function. They are equipped with sensors, microprocessors, and customizable settings, allowing users to adjust the device to their specific needs. This level of precision enhances patient outcomes and comfort. Advancements in medical technology have led to male artificial urinary sphincters with improved safety profiles. Modern devices are designed to minimize complications and side effects, making them a safer and more attractive option for both patients and healthcare providers. As these safety features become more pronounced, the market is likely to experience continued growth. Technological advancements have also led to the development of minimally invasive procedures for implanting male artificial urinary sphincters. These procedures are less traumatic for patients, resulting in reduced recovery times and improved overall patient experiences. Minimally invasive approaches have broadened the appeal of these devices and expanded their potential patient base. Technological advancements have also led to the development of minimally invasive procedures for implanting male artificial urinary sphincters. These procedures are less traumatic for patients, resulting in reduced recovery times and improved overall patient experiences. Minimally invasive approaches have broadened the appeal of these devices and expanded their potential patient base. The rise of telemedicine and remote monitoring has further accelerated the adoption of male artificial urinary sphincters. Patients can now consult with healthcare providers, receive device adjustments, and monitor their progress remotely, reducing the need for frequent in-person visits. This convenience factor is making the devices more accessible to a wider range of patients. Modern male artificial urinary sphincters are often designed with a patient-centered approach. Feedback from patients and healthcare professionals informs the design and functionality of these devices, ensuring that they meet the specific needs and preferences of users. This approach not only enhances patient satisfaction but also contributes to the continued growth of the market.

Quality of Life Considerations

Quality of life is a fundamental aspect of well-being, and advancements in healthcare technologies are increasingly focused on improving the lives of individuals affected by various medical conditions. In the realm of urology, male urinary incontinence can significantly compromise one's quality of life. Urinary incontinence is a condition characterized by the involuntary loss of urine, and it can have profound effects on an individual's daily life. Beyond the physical discomfort, the emotional and psychological toll of urinary incontinence can be substantial. Individuals often experience embarrassment, social isolation, a loss of self-esteem, and limitations on their daily activities. Quality of life considerations play a central role in driving the adoption of male artificial urinary sphincters. These devices offer individuals suffering from urinary incontinence a chance to regain their dignity and independence. By providing effective control over urinary function, male artificial urinary sphincters empower users to engage in activities they may have previously avoided, thereby improving their overall quality of life. The psychological well-being of individuals with urinary incontinence is a critical factor in their overall health. Constant worry about accidents, anxiety about social interactions, and the frustration of being unable to engage in once-loved activities can take a toll on mental health. Male artificial urinary sphincters address these concerns by offering a sense of security and control, ultimately contributing to better mental well-being. The social isolation experienced by many individuals with urinary incontinence can lead to feelings of loneliness and depression. Quality of life considerations are driving the use of male artificial urinary sphincters to facilitate social reintegration. These devices enable users to participate in social activities, maintain relationships, and lead more fulfilling lives. Urinary incontinence often disrupts sleep patterns, leading to fatigue and a reduced quality of life. Male artificial urinary sphincters can significantly reduce nighttime awakenings due to urinary urgency, allowing users to enjoy uninterrupted and restful sleep. This improved sleep quality contributes to overall well-being. The restoration of continence through male artificial urinary sphincters can boost self-esteem and confidence levels. When individuals regain control over their bladder, they often experience a sense of accomplishment and empowerment, leading to a more positive self-image and improved quality of life.

Key Market Challenges

High Cost of Treatment

One of the primary challenges facing the male artificial urinary sphincter market is the high cost associated with the treatment. The surgical procedure to implant these devices, along with the device itself, can be expensive. This poses a significant financial burden on patients, especially those without adequate health insurance coverage or access to healthcare resources.

Limited Access to Healthcare

Access to healthcare services varies widely around the world, and not all individuals have equal access to advanced treatments like male artificial urinary sphincters. Rural areas and underserved populations may face challenges in accessing specialized urological care and the necessary surgical procedures.

Inadequate Insurance Coverage

In many regions, insurance coverage for male artificial urinary sphincters may be limited or nonexistent. Patients may be required to bear a substantial portion of the costs themselves, discouraging some from seeking treatment.

Complications and Revision Surgery

While male artificial urinary sphincters are generally safe and effective, complications can occur, such as device malfunction or infection. These complications may necessitate revision surgeries, which can be challenging for patients both in terms of physical recovery and financial costs.

Key Market Trends

Minimally Invasive Procedures

A major trend on the horizon is the increasing adoption of minimally invasive procedures for the implantation of male artificial urinary sphincters. These techniques, often involving smaller incisions and less tissue disruption, offer patients shorter recovery times, reduced post-operative pain, and lower risk of complications. As minimally invasive procedures become more refined and accessible, they are likely to become the preferred approach for implanting these devices.

Enhanced Device Technology

Continual advancements in device technology are expected to drive innovation in the male artificial urinary sphincter market. Manufacturers are focusing on creating devices with improved precision, user-friendliness, and durability. Enhanced sensors, better control mechanisms, and connectivity options for remote monitoring are among the developments on the horizon. These technological enhancements will offer patients more personalized and effective solutions for managing urinary incontinence.

Customization and Personalization

Personalized healthcare is becoming increasingly important, and this trend is extending to the male artificial urinary sphincter market. Devices are being designed with greater flexibility to accommodate individual patient needs. Customization options for pressure settings, fluid volume, and timing of sphincter activation will enable urologists to tailor treatments to the unique requirements of each patient.

Telemedicine Integration

The integration of telemedicine and remote monitoring is expected to become a standard practice in the male artificial urinary sphincter market. Patients will have the ability to consult with healthcare providers, receive device adjustments, and monitor their progress remotely. This trend not only enhances patient convenience but also allows for more proactive and efficient management of urinary incontinence.

Segmental Insights

Type Insights

Based on the category of Type, the segment of Artificial Urinary Sphincters (AUS) featuring a three-component design with a balloon reservoir accounted for the largest market share. This type of AUS, which includes a balloon reservoir, is commonly employed for the treatment of urinary incontinence. The balloon reservoir serves as a storage unit for a fluid (typically saline) used to adjust the cuff surrounding the urethra, controlling the flow of urine.

During the forecast period, the AUS segment with a two-component design incorporating a spring is anticipated to experience the most rapid growth. A notable example is the ZSI 375, developed by Zephyr Surgical Implants in 2008, which is widely used. This particular AUS lacks an abdominal component and comes in a ready-to-implant configuration, reducing the time required for implantation. Additionally, it eliminates the need for surgical procedures in the retroperitoneal space due to the absence of an abdominal component. Furthermore, it allows for post-implantation adjustment of device pressure to achieve the desired continence rate. These advantages are expected to drive increased demand in the near future, resulting in a higher market share in terms of sales.

End-user Insights

the hospitals sector held a dominant position in the male artificial urinary sphincter market. This supremacy can be attributed to the increasing number of surgical procedures and a rising incidence of end-stage renal diseases. For instance, according to data from the CDC, in 2021, approximately 786,000 individuals in the United States underwent treatment for end-stage kidney disease, with roughly 71% undergoing dialysis and 29% receiving kidney transplants.

The segment comprising clinics and other healthcare centers is expected to experience significant growth at a considerable CAGR during the projected period. These clinics are well-equipped with the necessary medical instruments and infrastructure. Ambulatory Surgery Centers (ASCs) are specialized surgical facilities primarily focused on providing emergency or same-day surgical procedures and often linked to larger healthcare systems. ASCs offer a wide array of surgical treatments, including procedures for urinary incontinence (UI) such as sling procedures and artificial urinary sphincter (AUS) implantations, among others.

Additional healthcare facilities and centers encompass specialty surgical clinics, urology clinics, hospital-based clinics, and nonprofit healthcare systems. Furthermore, clinics present more cost-effective alternatives compared to hospitals for urological surgeries. As outpatient facilities, these clinics have lower overhead expenses and do not necessitate overnight stays, resulting in reduced overall costs for patients. They also offer shorter waiting times, adopt a patient-centered approach, and frequently employ specialized teams of urologists, nurses, and staff members who possess extensive experience and expertise in urologic surgeries.

Regional Insights

In 2022, Europe emerged as the dominant force in the market. The presence of advanced healthcare systems in Europe has resulted in increased life expectancy, leading to a growing aging population. Approximately one in five individuals in Europe is aged 65 or older, and this demographic group is more susceptible to urinary incontinence (UI). Additionally, the cost of surgical interventions to address UI is considerably higher for individuals. These factors collectively positioned Europe as the primary contributor to revenue in the artificial urinary sphincter market in 2022, and this trend is expected to persist throughout the forecast period.

The North American market for male artificial urinary sphincters is anticipated to experience substantial growth in the forecast period. This can be attributed to the region's well-established healthcare infrastructure, high prevalence of urological disorders, and a strong focus on technological advancements in medical devices. North America is a prominent market for male artificial urinary sphincters, as it is used to diagnose and treat various urological conditions, including kidney stones, enlarged prostates, bladder tumors, and urinary tract strictures, with advanced procedures such as the implantation of male artificial urinary sphincters.

In the United States, AUS has a long history of success among users. Furthermore, the AMS 800, an AUS device developed by Boston Scientific Corporation, has received approval from the U.S. Food and Drug Administration (FDA), ensuring its safety and effectiveness for users. Additionally, it is covered by insurance companies, making it more affordable and accessible to patients in the region.

Key Market Players

Boston Scientific Corporation

Zephyr Surgical Implants

Affluent Medical

UroMems

Rigicon

ProMinent GmbH

Report Scope:

In this report, the Global Male Artificial Urinary Sphincter Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Male Artificial Urinary Sphincter Market, By Type:

AUS with a balloon reservoir (3-component)
AUS with a spring (2-component)

Male Artificial Urinary Sphincter Market, By End-user:

Hospitals
Clinics & Other Healthcare Centers
Academic & Research Centers

Male Artificial Urinary Sphincter Market, By Region:

North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Asia-Pacific
China
Japan
India
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Male Artificial Urinary Sphincter Market.

Available Customizations:

Global Male Artificial Urinary Sphincter market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Male Artificial Urinary Sphincter Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Type (AUS with a balloon reservoir (3-component), AUS with a spring (2-component))
- 5.2.2. By End-user (Hospitals, Clinics & Other Healthcare Centers, Academic & Research Centers)
- 5.2.3. By Region
- 5.2.4. By Company (2022)
5.3. Product Market Map
- 5.3.1. By Type
- 5.3.2. By End-user
- 5.3.3. By Region

6. North America Male Artificial Urinary Sphincter Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Type (AUS with a balloon reservoir (3-component), AUS with a spring (2-component))
- 6.2.2. By End-user (Hospitals, Clinics & Other Healthcare Centers, Academic & Research Centers)
- 6.2.3. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Male Artificial Urinary Sphincter Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Type
    - 6.3.1.2.2. By End-user
- 6.3.2. Canada Male Artificial Urinary Sphincter Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Type
    - 6.3.2.2.2. By End-user
- 6.3.3. Mexico Male Artificial Urinary Sphincter Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Type
    - 6.3.3.2.2. By End-user

7. Europe Male Artificial Urinary Sphincter Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Type (AUS with a balloon reservoir (3-component), AUS with a spring (2-component))
- 7.2.2. By End-user (Hospitals, Clinics & Other Healthcare Centers, Academic & Research Centers)
- 7.2.3. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Male Artificial Urinary Sphincter Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Type
    - 7.3.1.2.2. By End-user
- 7.3.2. United Kingdom Male Artificial Urinary Sphincter Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Type
    - 7.3.2.2.2. By End-user
- 7.3.3. France Male Artificial Urinary Sphincter Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Type
    - 7.3.3.2.2. By End-user
- 7.3.4. Italy Male Artificial Urinary Sphincter Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Type
    - 7.3.4.2.2. By End-user
- 7.3.5. Spain Male Artificial Urinary Sphincter Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Type
    - 7.3.5.2.2. By End-user

8. Asia-Pacific Male Artificial Urinary Sphincter Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Type (AUS with a balloon reservoir (3-component), AUS with a spring (2-component))
- 8.2.2. By End-user (Hospitals, Clinics & Other Healthcare Centers, Academic & Research Centers)
- 8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Male Artificial Urinary Sphincter Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Type
    - 8.3.1.2.2. By End-user
- 8.3.2. Japan Male Artificial Urinary Sphincter Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Type
    - 8.3.2.2.2. By End-user
- 8.3.3. India Male Artificial Urinary Sphincter Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Type
    - 8.3.3.2.2. By End-user
- 8.3.4. Australia Male Artificial Urinary Sphincter Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Type
    - 8.3.4.2.2. By End-user
- 8.3.5. South Korea Male Artificial Urinary Sphincter Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Type
    - 8.3.5.2.2. By End-user

9. South America Male Artificial Urinary Sphincter Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Type (AUS with a balloon reservoir (3-component), AUS with a spring (2-component))
- 9.2.2. By End-user (Hospitals, Clinics & Other Healthcare Centers, Academic & Research Centers)
- 9.2.3. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Male Artificial Urinary Sphincter Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Type
    - 9.3.1.2.2. By End-user
- 9.3.2. Argentina Male Artificial Urinary Sphincter Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Type
    - 9.3.2.2.2. By End-user
- 9.3.3. Colombia Male Artificial Urinary Sphincter Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Type
    - 9.3.3.2.2. By End-user

10. Middle East and Africa Male Artificial Urinary Sphincter Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Type (AUS with a balloon reservoir (3-component), AUS with a spring (2-component))
- 10.2.2. By End-user (Hospitals, Clinics & Other Healthcare Centers, Academic & Research Centers)
- 10.2.3. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Male Artificial Urinary Sphincter Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Type
    - 10.3.1.2.2. By End-user
- 10.3.2. Saudi Arabia Male Artificial Urinary Sphincter Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Type
    - 10.3.2.2.2. By End-user
- 10.3.3. UAE Male Artificial Urinary Sphincter Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Type
    - 10.3.3.2.2. By End-user
- 10.3.4. Kuwait Male Artificial Urinary Sphincter Market Outlook
  - 10.3.4.1. Market Size & Forecast
    - 10.3.4.1.1. By Value
  - 10.3.4.2. Market Share & Forecast
    - 10.3.4.2.1. By Type
    - 10.3.4.2.2. By End-user

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches

13. Porter's Five Forces Analysis

13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products

14. Competitive Landscape

14.1. Business Overview
14.2. Product Offerings
14.3. Recent Developments
14.4. Financials (As Reported)
14.5. Key Personnel
14.6. SWOT Analysis
- 14.6.1. Boston Scientific Corporation
- 14.6.2. Zephyr Surgical Implants
- 14.6.3. Affluent Medical
- 14.6.4. UroMems
- 14.6.5. Rigicon
- 14.6.6. ProMinent GmbH